Skip to the page

Data / Form D filings / Anodyne Nanotech, Inc.

Anodyne Nanotech, Inc.: Form D filings

Anodyne Nanotech, Inc., a health care company in Boston, MA, filed 4 Form D notices with the SEC between 2020 and 2026. The latest, on June 11, 2026, reports $12.6 million sold of a $17.3 million offering to 47 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
38 Wareham Street, 3rd Floor, Boston, MA, 02118
Phone
(732) 503-3865
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1818572

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 11, 2026New notice$17,259,023$12,597,058$4,661,96547May 27, 2026sec.gov
May 7, 2021Amendment$1,957,280$1,957,28015Feb 19, 2021sec.gov
Feb 25, 2021New notice$2,000,000$1,715,000$285,0006Feb 19, 2021sec.gov
Aug 7, 2020New notice$2,304,416$1,469,417$834,99920Jul 24, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jake LombardoExecutive Officer, Director
Konstantinos TzortzakisExecutive Officer, Director
Georgios PapastergiouDirector
Michael SingerDirector
Vikram LambaDirector

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Jun 8, 2026 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Anodyne Nanotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.